Medworxx Solutions Inc.
TSX VENTURE : MWX

Medworxx Solutions Inc.

October 15, 2015 13:30 ET

Aptean, Inc. Completes Acquisition of Medworxx Solutions Inc.

TORONTO, ONTARIO--(Marketwired - Oct. 15, 2015) - Medworxx Solutions Inc. (TSX VENTURE:MWX) ("Medworxx") and Aptean, Inc. ("Aptean") are pleased to announce the successful completion of the previously announced plan of arrangement (the "Arrangement") involving Medworxx and an affiliate of Aptean. The Arrangement was completed pursuant to the terms and conditions of an arrangement agreement dated August 27, 2015 between Medworxx, 1047100 B.C. Ltd. and Aptean Patent Co. SARL, and effected by way of a plan of arrangement under the Canada Business Corporations Act.

As previously announced, Medworxx's shareholders approved the Arrangement at a special meeting of shareholders held on October 8, 2015. The Arrangement was subsequently approved by the Superior Court of Ontario at a hearing held on October 13, 2015.

Pursuant to the Arrangement, Aptean beneficially acquired all of the issued and outstanding class A common shares (the "Common Shares") of Medworxx for aggregate consideration of CDN$15,876,823. Each Common Share was acquired by Aptean at a price per Common Share of CDN$0.5656 (the "Cash Consideration"). The Common Shares are expected to be delisted from the TSX Venture Exchange at the close of business on or around October 16, 2015.

In order to receive the Cash Consideration in exchange for their Common Shares, registered shareholders must complete, sign, date and return the letter of transmittal that was mailed to each registered shareholder. The letter of transmittal is also available from Medworxx's depositary, Equity Financial Trust Company, by telephone toll-free at 1 (866) 393-4891 or by email at TMXEInvestorServices@tmx.com, and under Medworxx's profile on at www.sedar.com.

A shareholder who's Common Shares are registered in the name of a broker, investment dealer, bank, trust company, trustee or other intermediary or nominee should contact that intermediary or nominee for instructions and assistance in depositing their Common Shares.

About Medworxx

Medworxx delivers health information solutions to over 350 hospitals internationally; including Canada, United States and United Kingdom. Medworxx helps hospitals meet patient flow challenges and requirements in compliance and education. Medworxx Clinical Criteria- flagship of Medworxx Patient Flow that includes electronic bed board and independent assessment components - currently serves over 34% of the acute care beds in Canada. Founded in 2004, Medworxx is based in Toronto, Ontario. For more information, visit www.medworxx.com.

About Aptean

Aptean is a leading provider of industry-focused mission critical enterprise software solutions. We build and acquire solutions to support the evolving operational needs of our customers. Our solutions help nearly 5,000 organizations stay at the forefront of their industries by satisfying their customers and continuing to operate more efficiently. For more information, visit www.aptean.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or "recurring" or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as the risk that the Common Shares may not be delisted from the TSX Venture Exchange as anticipated.

Contact Information